Skip to content
HowShorted

How shorted was Verve Therapeutics, Inc.? VERV

Verve Therapeutics, Inc. left the US market in 2025. This page is a frozen archive of its reported short interest, ending 30 Jun 2025. The ticker VERV no longer refers to this company and may since have been reassigned.
11.09%
of shares outstanding reported short · settlement date 30 Jun 2025
vs previous report
−9.10
5 reports (~10 weeks)
−8.47
days to cover
1.00
Aggregate net short position time series for Verve Therapeutics, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Verve Therapeutics, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
14 May 202521.87% 30 Apr 202520.65% 15 May 2025−1.22
27 Feb 202516.56% 14 Feb 202517.56% 28 Feb 2025+1.00
5 Nov 202420.35% 31 Oct 202420.17% 15 Nov 2024−0.18
8 Aug 202419.33% 31 Jul 202419.20% 15 Aug 2024−0.13
8 May 202419.78% 30 Apr 202420.95% 15 May 2024+1.17
27 Feb 202415.05% 15 Feb 202414.97% 29 Feb 2024−0.08
7 Nov 202319.90% 31 Oct 202320.94% 15 Nov 2023+1.04
10 Aug 202317.28% 31 Jul 202317.53% 15 Aug 2023+0.25
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Share on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2021 · 2022 · 2023 · 2024 · 2025

History

Full reported short interest history
Settlement dateShort %Change
30 Jun 202511.09%−9.10
13 Jun 202520.19%−2.07
30 May 202522.26%+1.61
15 May 202520.65%−1.22
30 Apr 202521.87%+2.31
15 Apr 202519.56%−0.08
31 Mar 202519.64%+1.60
14 Mar 202518.04%+0.48
28 Feb 202517.56%+1.00
14 Feb 202516.56%+0.91
31 Jan 202515.65%−1.82
15 Jan 202517.47%+0.68
31 Dec 202416.79%−2.08
13 Dec 202418.87%−2.24
29 Nov 202421.11%+0.94
15 Nov 202420.17%−0.18
31 Oct 202420.35%−0.26
15 Oct 202420.61%+0.64
30 Sep 202419.97%+1.22
13 Sep 202418.75%−0.54
30 Aug 202419.29%+0.09
15 Aug 202419.20%−0.13
31 Jul 202419.33%+0.99
15 Jul 202418.34%+0.26
28 Jun 202418.08%−2.93
14 Jun 202421.01%−1.27
31 May 202422.28%+1.33
15 May 202420.95%+1.17
30 Apr 202419.78%+1.01
15 Apr 202418.77%+0.40
28 Mar 202418.37%+1.50
15 Mar 202416.87%+1.90
29 Feb 202414.97%−0.08
15 Feb 202415.05%+0.25
31 Jan 202414.80%+0.02
12 Jan 202414.78%−3.62
29 Dec 202318.40%+0.77
15 Dec 202317.63%−4.93
30 Nov 202322.56%+1.62
15 Nov 202320.94%+1.04
31 Oct 202319.90%+1.99
13 Oct 202317.91%−1.21
29 Sep 202319.12%+0.38
15 Sep 202318.74%+0.03
31 Aug 202318.71%+1.18
15 Aug 202317.53%+0.25
31 Jul 202317.28%−1.96
14 Jul 202319.24%+0.08
30 Jun 202319.16%+0.49
15 Jun 202318.67%−1.33
31 May 202320.00%−0.38
15 May 202320.38%−0.84
28 Apr 202321.22%−0.50
14 Apr 202321.72%−0.11
31 Mar 202321.83%−0.32
15 Mar 202322.15%−0.01
28 Feb 202322.16%+0.13
15 Feb 202322.03%+1.22
31 Jan 202320.81%+0.04
13 Jan 202320.77%+0.53
30 Dec 202220.24%+2.45
15 Dec 202217.79%+1.37
30 Nov 202216.42%+0.22
15 Nov 202216.20%−0.57
31 Oct 202216.77%−1.13
14 Oct 202217.90%−2.33
30 Sep 202220.23%+3.79
15 Sep 202216.44%+0.31
31 Aug 202216.13%+0.13
15 Aug 202216.00%−2.38
29 Jul 202218.38%−2.05
15 Jul 202220.43%+1.10
30 Jun 202219.33%−1.13
15 Jun 202220.46%+0.68
31 May 202219.78%+0.43
13 May 202219.35%+0.82
29 Apr 202218.53%+1.17
14 Apr 202217.36%−0.62
31 Mar 202217.98%+1.28
15 Mar 202216.70%+0.73
28 Feb 202215.97%+0.16
15 Feb 202215.81%+1.51
31 Jan 202214.30%+1.44
14 Jan 202212.86%+0.12
31 Dec 202112.74%+0.99
15 Dec 202111.75%+2.09
30 Nov 20219.66%+1.68
15 Nov 20217.98%+1.06
29 Oct 20216.92%+0.71
15 Oct 20216.21%+1.58
30 Sep 20214.63%+0.70
15 Sep 20213.93%+0.05
31 Aug 20213.88%+0.57
13 Aug 20213.31%–

Newest first. Scroll inside the table for earlier dates, back to 13 Aug 2021.

Frequently asked questions

How shorted was Verve Therapeutics, Inc.?
Verve Therapeutics, Inc. left the US market in 2025. Its final reported figure was 11.09% of shares outstanding for settlement date 30 Jun 2025, per FINRA's consolidated short interest report; this page preserves its full history.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this VERV's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is VERV's days to cover?
1.00 days for settlement date 30 Jun 2025: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.